Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial.

M M Berger, M J Reymond, A Shenkin, F Rey, C Wardle, C Cayeux, C Schindler, R L Chioléro

Journal: Intensive care medicine 2001;27(1):91-100

PMID: 11280679

Abstract

OBJECTIVE

To investigate whether early selenium (Se) supplementation can modify the post-traumatic alterations of thyroid hormone metabolism, since the first week after trauma is characterised by low plasma Se and negative Se balances.

DESIGN

Prospective, placebo-controlled randomised supplementation trial.

SETTING

Surgical ICU in a tertiary university hospital.

PATIENTS

Thirty-one critically ill trauma patients aged 42 +/- 16 years (mean +/- SD), with severe multiple injury (Injury Severity Score 30 +/- 7).

INTERVENTION

Supplementation during the first 5 days after injury with either Se or placebo. The selenium group was further randomised to receive daily 500 microg Se, with or without 150 mg alpha-tocopherol (AT) and 13 mg zinc supplements. The placebo group received the vehicle. Circulating Se, AT, zinc, and thyroid hormones were determined on D0 (= day 0, admission), D1, D2, D5, D10, and D20.

RESULTS

Plasma Se, low on D0, normalised from D1 in the selenium group; total T4 and T3 increased more and faster after D2 (P = 0.04 and 0.08), reverse T3 rising less between D0 and D2 (P = 0.05).

CONCLUSIONS

Selenium supplements increased the circulating Se levels. Supplementation was associated with modest changes in thyroid hormones, with an earlier normalisation of T4 and reverse T3 plasma levels. The addition of AT and zinc did not produce any additional change.

Address: Soins Intensifs de Chirurgie, CHUV, Lausanne, Switzerland. [email protected]

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.